Home > Journals > Indian Journal of Anesthesia and Analgesia

Indian Journal of Anesthesia and Analgesia

Submit your article Read this Journals View all journals
Full Text (PDF)
Original Article

Comparative Evaluation of Nalbuphine and Tramadol as an Adjuvant to 0.5% Bupivacaine in Supraclavicular Brachial Plexus Block

Ashwini Khamborkar , Bhavini Shah1 , Guneet Chadha2 , Ashwini Khamborkar3 , Rakesh D4 , Shweta Birajdar5 , Shreyank Solanki6

Author Information

Licence:



Indian Journal of Anesthesia and Analgesia 6(5):p 1511-1516, September-October 2019. | DOI: http://dx.doi.org/10.21088/ijaa.2349.8471.6519.3

How Cite This Article:

Bhavini Shah, Guneet Chadha, Ashwini Khamborkar. Comparative Evaluation of Nalbuphine and Tramadol as an Adjuvant to 0.5% Bupivacaine in Supraclavicular Brachial Plexus Block. Indian J Anesth Analg. 2019;6(5 Part-1):1511-1516.

Timeline

Received : N/A         Accepted : N/A          Published : N/A

Abstract

Background: Brachial plexus block is a reliable, regional anesthetic technique for upper arm surgeries. Opioid agonist-antagonists are used as adjuvant to enhance the analgesia of bupivacaine. The present study was aimed to compare the analgesic efficacy and safety of nalbuphine and tramadol as an adjuvant to 0.5% bupivacaine for brachial plexus block. Materials and Methods: Thirty adult patients of ASA I and II of both genders were randomized into two Groups of fifteen patients, Group BT receive 28 ml of 0.5% bupivacaine with 2 ml of tramadol and Group BN receive 28 ml of 0.5% bupivacaine with 2 ml of nalbuphine 20 mg for supraclavicular brachial plexus block. Patients were observed for onset and duration of sensory and motor block with duration of pain relief as primary end points while occurrence of any adverse effect due to technique or nalbuphine was noted as secondary outcome. Results: In Group BN, there was a statistically significant shorter time to onset of sensory blockade (10.46 ± 1.5 min vs 13.66 ± 2.5 min, p < 0.001), shorter onset time to achieve motor block (14.4 ± 2.5 min vs. 18.46 ± 3.5 min, p < 0.001), longer duration of motor block (291.4 min vs 363.07 min, p < 0.001), and prolonged analgesia (456 min vs 409.13 min, p = 0.003). No significant side effects were seen in any of the groups. Conclusion: Addition of nalbuphine to 0.5% bupivacaine in supraclavicular brachial plexus block significantly hastens the onset, and prolongs the duration of sensorimotor blockade and analgesia when compared with tramadol as an additive. Both the drugs were comparable in terms of safety.

References

No records found.


About this article

Cite this article

Bhavini Shah, Guneet Chadha, Ashwini Khamborkar. Comparative Evaluation of Nalbuphine and Tramadol as an Adjuvant to 0.5% Bupivacaine in Supraclavicular Brachial Plexus Block. Indian J Anesth Analg. 2019;6(5 Part-1):1511-1516.

Licence:



Received Accepted Published
N/A N/A N/A
DOI: http://dx.doi.org/10.21088/ijaa.2349.8471.6519.3

Keywords

Brachial plexus block; Bupivacaine; Nalbuphine; Tramadol; Additive.

Article Level Metrics

Last Updated

Saturday 28 February 2026, 16:43:27 (IST)

1389

Accesses

0
245
00

Citations


NA
NA
NA

Download citation


Article Keywords

Keyword Highlighting

Highlight selected keywords in the article text.


Timeline

Received N/A
Accepted N/A
Published N/A

licence




Access this article

Reprint Order Form
Buy this Article
Institutional Subscriptions

Share